Your browser doesn't support javascript.
loading
Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions.
Sucker, Antje; Zhao, Fang; Pieper, Natalia; Heeke, Christina; Maltaner, Raffaela; Stadtler, Nadine; Real, Birgit; Bielefeld, Nicola; Howe, Sebastian; Weide, Benjamin; Gutzmer, Ralf; Utikal, Jochen; Loquai, Carmen; Gogas, Helen; Klein-Hitpass, Ludger; Zeschnigk, Michael; Westendorf, Astrid M; Trilling, Mirko; Horn, Susanne; Schilling, Bastian; Schadendorf, Dirk; Griewank, Klaus G; Paschen, Annette.
Afiliación
  • Sucker A; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany.
  • Zhao F; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, 45122 Essen, Germany.
  • Pieper N; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany.
  • Heeke C; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, 45122 Essen, Germany.
  • Maltaner R; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany.
  • Stadtler N; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, 45122 Essen, Germany.
  • Real B; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany.
  • Bielefeld N; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, 45122 Essen, Germany.
  • Howe S; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany.
  • Weide B; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, 45122 Essen, Germany.
  • Gutzmer R; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany.
  • Utikal J; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, 45122 Essen, Germany.
  • Loquai C; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany.
  • Gogas H; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, 45122 Essen, Germany.
  • Klein-Hitpass L; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany.
  • Zeschnigk M; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, 45122 Essen, Germany.
  • Westendorf AM; Institute of Virology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany.
  • Trilling M; Division of Dermatooncology, Department of Dermatology, University Medical Center Tübingen, 72076 Tübingen, Germany.
  • Horn S; Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, 30625 Hannover, Germany.
  • Schilling B; German Cancer Research Center (DKFZ), Skin Cancer Unit, Heidelberg and University Medical Center Mannheim, Department of Dermatology, Venereology and Allergology, Ruprecht-Karl University of Heidelberg, 68167 Mannheim, Germany.
  • Schadendorf D; Skin Cancer Center, Department of Dermatology, University of Mainz Medical Center, 55131 Mainz, Germany.
  • Griewank KG; First Department of Medicine,National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Paschen A; Institute of Cell Biology, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Nat Commun ; 8: 15440, 2017 05 31.
Article en En | MEDLINE | ID: mdl-28561041
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Linfocitos T / Interferón gamma / Escape del Tumor / Resistencia a Antineoplásicos / Melanoma Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2017 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Linfocitos T / Interferón gamma / Escape del Tumor / Resistencia a Antineoplásicos / Melanoma Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2017 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido